BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Lone Star Bio

  SpinalCyte, LLC Announces 25th Patent

  The company has received confirmation of the issuance of European Patent No. 2776556, “Fibroblasts For Treatment Of Degenerative Disc Disease.”

  December 27, 2017

   · 

  1 min read
• 

  BioMidwest

  PharMEDium Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products Due to Lack of Sterility Assurance

  To date, PharMEDium has not received any reports of complaints related to the products but is issuing this recall out of an abundance of caution following a commitment made during a recent inspection of the company’s facility.

  December 27, 2017

   · 

  14 min read
• Policy

  CStone Files CS1003, an Anti-PD-1 Antibody, for Clinical Trial Approval in Australia

  CStone today announced that a formal application for clinical trial approval has been submitted to Human Research Ethics Committees of the Scientia Clinical Research center in Australia for the anti-programmed death-1 (PD-1) mAb candidate CS1003.

  December 27, 2017

   · 

  4 min read
• Ablynx Release: Notice in Relation to Waiver of Lock-Up Restriction

  The waiver will take effect on 29 December 2017 and the securities may be sold on or after such date.

  December 27, 2017

   · 

  2 min read
• Drug Development

  FDA Approves Nanobiotix’s First Immuno-Oncology Trial

  First Nanobiotix immuno-oncology trial will be conducted in the U.S.

  December 27, 2017

   · 

  9 min read
• Novo Nordisk A/S: Share Repurchase Programme – Dec. 27, 2017

  This programme is part of the overall share repurchase programme of up to DKK 17 billion to be executed during a 12-month period beginning 2 February 2017.

  December 27, 2017

   · 

  1 min read
• Biotech Beach

  Safer Lock Release: City of Citrus Heights Offers Free Safer Locks to Protect Residents From Accidental Poisonings and Addiction

  In a ground-breaking program designed to prevent accidental poisoning and addiction, the City of Citrus Heights, California, will provide 1,000 Safer Lock prescription bottles with locking caps to Citrus Heights parents.

  December 27, 2017

   · 

  3 min read
• Drug Development

  Innovation Pharmaceuticals Obtains Direct Evidence of Molecular Pathways Modulation in Tumors From First Patients in Kevetrin PhIIa Ovarian Cancer Trial

  The findings confirm in patient tumors Kevetrin-induced anti-cancer effects similar to those demonstrated (pdf) preclinically in ovarian cancer cell-lines.

  December 27, 2017

   · 

  9 min read
• Pharm Country

  Helius Medical Technologies Announces Closing of First Tranche of Private Placement

  The net proceeds of the Private Placement will be used by the Company to finance the Company’s near-term operations and more.

  December 27, 2017

   · 

  8 min read
• Deals

  Summit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva Ltd.

  Under the deal, Summit acquired 100% of the issued share capital of Discuva.

  December 27, 2017

   · 

  9 min read